This analyst has concerns about the Pfizer and BioNTech vaccine
CNBC's Kelly Evans discusses vaccine stocks, and why there are concerns about vaccine effectiveness, with Dr. Vincent Chen, biotech analyst at Bernstein. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: https://www.cnbc.com/2020/09/29/the-news-with-shepard-smith-podcast.html?__source=youtube%7Cshepsmith%7Cpodcast
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
https://www.cnbc.com/select/best-credit-cards/
#CNBC
#CNBCTV
Видео This analyst has concerns about the Pfizer and BioNTech vaccine канала CNBC Television
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: https://www.cnbc.com/2020/09/29/the-news-with-shepard-smith-podcast.html?__source=youtube%7Cshepsmith%7Cpodcast
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
https://www.cnbc.com/select/best-credit-cards/
#CNBC
#CNBCTV
Видео This analyst has concerns about the Pfizer and BioNTech vaccine канала CNBC Television
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
The perils of developing a vaccine at warp speed | CNBC Explains350,000 Ring doorbells recalled over fire, burn hazardsThere will be big upside following current choppiness: Fundstrat's Tom LeeRay Dalio weighs in on financial markets, a history of world order and central banks plus moreCoronavirus Vaccine Update With Paul OffitOnly half way through the sell-off, warns MS's Mike WilsonPfizer board member Dr. Scott Gottlieb on company's vaccine timelinePfizer CEO On Coronavirus Vaccine: ‘We Will Have An Answer By The End Of October’ | TODAYMarket is treating a vaccine as a binary event, and that may not be true: Art CashinBioNTech Aktie: Der Impfstoff kommt (100% Kursgewinn?!)What Is An mRNA Coronavirus Vaccine?Oversold extreme suggests further weakness should be temporary: Canaccord's DwyerIf Big Tech earnings disappoint, it'll cause more investor uncertainty: ProIs The Market Right To Get Excited About The Latest Pfizer Vaccine Results?An inside look at Pfizer's Phase 3 COVID-19 vaccine trialPfizer's chief scientific officer talks COVID-19 vaccine’s 90% effectivenessWatch CNBC's full interview with Berkshire Hathaway CEO Warren BuffettJim Cramer: Trump's election dispute is a problem for the marketThree charts that tell the true tale of the marketThe safety and efficacy for Covid-19 vaccine has never been higher, it looks promising: Dr. Francis